CXCL12 and amyotrophic lateral sclerosis: Based on CSF results, we decided to evaluate the diagnostic ability of CXCL12 levels in plasma, a more accessible biofluid, and compare to NF-L’s accuracy to differentiate between HC and amyotrophic lateral sclerosis patients.